Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 27;7(2):253-255.
doi: 10.3889/oamjms.2019.065. eCollection 2019 Jan 30.

Successful Psoriasis Treatment Using NB-UVB with Methotrexate: The Vietnamese Experience

Affiliations

Successful Psoriasis Treatment Using NB-UVB with Methotrexate: The Vietnamese Experience

Em Dang Van et al. Open Access Maced J Med Sci. .

Abstract

Aim: To compare the effectiveness of narrowband ultraviolet B (NBUVB) and oral methotrexate (MTX) to oral MTX alone in Vietnamese psoriasis patients, from May 2016 to May 2018.

Methods: We conducted a non-randomized trial on 70 patients with plaque-type psoriasis of moderate to severe. Thirty-five patients apply NBUVB once/day in 5 days/week for 4 weeks plus oral MTX 7.5 mg/week and 35 patients oral MTX 7.5 mg/week and both two groups treatment for 3 months. The extent of the lesion was assessed by the Psoriasis Area and Severity Index (PASI).

Results: The proportion of decreasing PASI was comparable (68.49% in NBUVB and MTX versus 57.62% in MTX alone); p < 0.05. Inside, good 28.58%, moderate 68.57% and poor 2.85% in NBUVB and MTX better than good 2.85%, moderate 71.4% and poor 25.72% in MTX alone; p < 0.05. The recurrence rate after 24 months of the NBUVB and MTX group (42.9%) was lower than the MTX alone group (71.4%); p < 0.05.

Conclusion: NBUVB and oral MTX have affected treatment with chronic plaque psoriasis better than oral MTX alone.

Keywords: Methotrexate; Narrowband ultraviolet B; Psoriasis vulgaris.

PubMed Disclaimer

References

    1. Habif TP. Skin disease, Diagnosis and treatment. second edition. Elsevier Mosby; 2010. pp. 106–115.
    1. Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S. Interleukin 17A:toward a new understanding of psoriasis pathogenesis. Journal of the American Academy of Dermatology. 2014;71(1):141–50. https://doi.org/10.1016/j.jaad.2013.12.036 PMid:24655820. - PubMed
    1. Mizutani H, Ohmoto Y, Mizutani T, Murata M, Shimizu M. Role of increased production of monocytes TNF-α, IL-1βand IL-6 in psoriasis:relation to focal infection, disease activity and responses to treatments. Journal of dermatological science. 1997;14(2):145–53. https://doi.org/10.1016/S0923-1811(96)00562-2. - PubMed
    1. Soliman A. Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis. J Dermatology Treat. 2015;3:234–327. https://doi.org/10.3109/09546634.2015.1034069. - PubMed
    1. Mahajan R, Kaur I, Kanwar AJ. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis–a randomized single-blinded placebo-controlled study. Journal of the European Academy of Dermatology and Venereology. 2010;24(5):595–600. https://doi.org/10.1111/j.1468-3083.2009.03486.x PMid:20015056. - PubMed

LinkOut - more resources